Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ASCO 2020 | Targeted therapy in NSCLC at ASCO 2020

Riyaz Shah, FRCP, PhD, Maidstone and Tunbridge Wells NHS Trust, Kent, UK, gives his thoughts on the data coming from the ADAURA study (NCT02511106) and other targeted therapies in the treatment of non-small cell lung cancer. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).